PUBLISHER: The Business Research Company | PRODUCT CODE: 1764247
PUBLISHER: The Business Research Company | PRODUCT CODE: 1764247
Appetite control and suppressants encompass a range of methods, substances, and strategies aimed at managing hunger and reducing the urge to eat, thereby supporting weight management. These approaches can be natural-such as consuming high-fiber or high-protein foods, staying well-hydrated, and maintaining regular sleep and stress levels-or medical, including pharmaceutical interventions designed to suppress appetite.
The primary product categories include prescription appetite suppressants, over-the-counter (OTC) suppressants, natural or herbal alternatives, meal replacements and shakes, and dietary fiber supplements. Prescription suppressants are medications provided by healthcare professionals to help curb hunger or cravings and support weight loss efforts. These products come in various forms, including tablets and capsules, powders, gummies and chews, liquids, and bars. Distribution channels include pharmacies and drugstores, supermarkets and hypermarkets, online retailers, specialty stores, and healthcare clinics. The target end-user groups consist of adults, the elderly, and adolescents.
The appetite control and suppressant market research report is one of a series of new reports from The Business Research Company that cover appetite control and suppressant market statistics, including the appetite control and suppressant industry's global market size, regional shares, competitors with the appetite control and suppressant market share, detailed appetite control and suppressant market segments, market trends and opportunities, and any further data you may need to thrive in the appetite control and suppressant market. This appetite control and suppressant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The appetite control and suppressants market size has grown strongly in recent years. It will grow from $3.59 billion in 2024 to $3.84 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%./b> Growth during the historic period can be attributed to several key factors, including increased awareness of the health risks associated with obesity, the rising popularity of natural and herbal supplements, a growing prevalence of lifestyle-related diseases, greater accessibility to over-the-counter weight loss products, and the widespread adoption of low-calorie diets and intermittent fasting practices.
The appetite control and suppressants market size is expected to see strong growth in the next few years. It will grow to $5.01 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%./b> Growth in the forecast period is expected to be driven by a heightened focus on preventive healthcare and weight management, increased demand for personalized nutrition and weight loss solutions, growing popularity of vegan and keto diet plans, rising consumer preference for organic and clean-label products, and the strong influence of social media on body image and wellness trends. Key trends anticipated include the development of multi-target appetite suppressants, integration of suppressants with behavioral therapy, incorporation into telehealth platforms, innovation in synthetic appetite-suppressing compounds, and the advancement of long-acting formulations for sustained appetite control.
The increasing prevalence of overweight and obesity is expected to drive the growth of the appetite control and suppressants market in the coming years. Overweight and obesity are conditions characterized by excessive fat accumulation that can negatively impact health. This rising trend is largely attributed to diets high in calories, sugars, and unhealthy fats, coupled with inadequate nutrient intake and physical inactivity. Appetite control and suppressant products support weight management by reducing hunger signals, curbing calorie consumption, and promoting healthier eating habits. For example, in September 2023, the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, reported that in 2022, 35% or more of adults in the United States were classified as obese-an increase from 19 states reporting similar rates in 2021. This growing concern over obesity is contributing significantly to the expansion of the appetite control and suppressants market.
Major players in the appetite control and suppressants market are emphasizing innovation by developing new products such as natural appetite suppressant drinks, aimed at providing safer and more effective weight management options. These drinks are typically made from herbs, fruits, or dietary fibers that naturally help curb hunger and reduce food cravings. For example, in December 2024, Nestle S.A., a Switzerland-based food and beverage company, introduced Boost Pre-Meal Hunger Support, a natural appetite suppressant drink. Designed to emulate the appetite-reducing effects of medications like Ozempic and Wegovy, the product is a 45-calorie, 10-gram whey protein shot intended to be taken 10 to 30 minutes before meals. It stimulates the body's natural GLP-1 hormone response, helping to suppress appetite and enhance satiety. The formula features fast-digesting peptides and whey protein microgels that help prolong feelings of fullness, making it especially suitable for individuals following weight-loss plans or using GLP-1-based therapies.
In March 2022, Pfizer Inc., a U.S.-based pharmaceutical and biotechnology company, acquired Arena Pharmaceuticals Inc. for an undisclosed amount. This acquisition was aimed at enhancing Pfizer's immuno-inflammatory and cardiovascular treatment portfolio by leveraging Arena's innovative therapies and accelerating their clinical development pipeline. Arena Pharmaceuticals Inc., a U.S.-based biotech firm, had previously developed the appetite suppressant medication Belviq, contributing to its expertise in weight management and metabolic disorder treatments.
Major players in the appetite control and suppressants market are Nestle S.A, Pfizer Inc., AbbVie Inc., Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Herbalife Nutrition Ltd, Amway Corporation, GNC Holdings, Inc., Medifast Inc, Nature's Sunshine Products, Inc., The Boots Company PLC, BPI Sports LLC, Grenade (UK) Limited, Currax Pharmaceuticals LLC, VIVUS Inc, Orexigen Therapeutics Inc, NOW Health Group Inc, Nutrabay Retail Private Limited, GAT Sport.
North America was the largest region in the appetite control and suppressants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in appetite control and suppressants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the appetite control and suppressants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The appetite control and suppressants market consist of sales of thermogenic appetite suppressants, serotonin-based appetite suppressants, fat binders, stimulant-free appetite suppressants, lipase inhibitors, glucomannan-based supplements, and garcinia cambogia-based products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Appetite Control And Suppressants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on appetite control and suppressants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for appetite control and suppressants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The appetite control and suppressants market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Subsegments